Oryzon Genomics SA

Oryzon Genomics SA

Oryzon Genomics SA

Overview
Date Founded

2000

Headquarters

Sant Ferran 74,Cornellà de Llobregat,Barcelona, Catalonia 08940

Type of Company

Public

Employees (Worldwide)

40

Industries

Biotechnology
Pharmaceuticals
Medical Support Services

Company Description

Oryzon Genomics SA engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. It focuses on epigenetics in various therapeutic indications, with a special emphasis on oncology and neurodegenerative disease. The company was founded by Carlos Manuel Buesa Arjol and Tamara Maes on June 2, 2000 and is headquartered in Barcelona, Spain.

Executives & Employees

Founder & Chief Executive Officer

Chief Operating & Financial Officer

First Deputy Chairman & Chief Scientific Officer

Chief Business Development Officer

Chief Intellectual Property Officer

Chief Medical Officer

Investor Relations Director (IR)

Director & Head-Financial Operations

Director of Drug Discovery

Vice President-Clinical Portfolio & Innovation

Board of Directors

Founder & Chief Executive Officer at Oryzon Genomics SA

Managing Partner at Inveready Asset Management SGEIC SA

Global Head of Drug Discovery at AbbVie, Inc.

Associate Professor at Escuela Superior de Administración y Dirección de Empresas

First Deputy Chairman & Chief Scientific Officer at Oryzon Genomics SA

Vice President at CEDE Foundation

Managing Director at Bay City Capital LLC

Professor at University of Cadiz

Paths to Oryzon Genomics SA
Potential Connections via
Relationship Science
You
Oryzon Genomics SA
Owners & Shareholders
Details Hidden

Solventis SGIIC SA, a subsidiary of Solventis AV SA, is a company headquartered in Barcelona, Spain. The firm provides investment advice. It was founded in 2016. Ramiro Martínez-Pardo del Valle has been the CEO since the inception date.

Details Hidden

Gesinter is an active manager which follows a growth-oriented investment style. They invest globally in equity securities across all market caps and sectors with the bulk of their assets allocated to Continental European companies. The firm follows a bottom-up research approach, supplemented by technical, fundamental and qualitative and quantitative analyses

Details Hidden

GAR Investment Managers SARL is a private company headquartered in Luxembourg, Luxembourg, that operates in several countries. The firm provides investment advice. Rafael Rabat is the current CEO of the company.

Recent Transactions
Details Hidden

Laboratorio Reig Jofre SA purchases Oryzon Genomics Diagnóstico SL from Oryzon Genomics SA

Details Hidden

Oryzon Genomics SA issued EUR Ordinary Shares

Details Hidden

Oryzon Genomics SA, Debaeque SGEIC SA, Najeti SL, Corporación Sant Bernat purchase Crystax Pharmaceuticals SL from Highgrowth Partners SGECR SA

Advisors & Consultants
Legal Advisor

Partner at Davis Polk & Wardwell LLP

Publicist

Former Senior Vice President at Trout Capital LLC

Publicist

Professional at Atrevia

Key Stats and Financials As of 2019
Market Capitalization
$168M
Total Enterprise Value
$93.6M
Earnings Per Share
$-0.09
Revenue
$0
Net Profit
$-3.68M
EBITDA
$-3.71M
Total Debt
$13.2M
Total Equity
$56M
TEVNet Income
-25.4x
Debt TEV
0.14x
Three Year Compounded Annual Growth Rate Of Revenue
-100%
Five Year Compounded Annual Growth Rate Of Revenue
-100%
Investors
Details Hidden

Founder at Crystax Pharmaceuticals SL

Details Hidden

Founder & Chief Executive Officer at Oryzon Genomics SA

Details Hidden

Former Scientific Advisor at Crystax Pharmaceuticals SL

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Oryzon Genomics SA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Oryzon Genomics SA's profile does not indicate a business or promotional relationship of any kind between RelSci and Oryzon Genomics SA.